After early hopes AstraZeneca-Oxford vaccine suffers setbacks
The coronavirus vaccine developed in Britain by Oxford University and UK-Swedish pharmaceutical firm AstraZeneca has suffered several setbacks since its development, dampening hopes over its global role in ending the pandemic.